Trial Profile
Single-center, Open-label, Randomized, Two-way Crossover Study to Investigate the Absolute Bioavailability of a Single Oral Dose of Ponesimod in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Ponesimod (Primary) ; Ponesimod (Primary)
- Indications Graft-versus-host disease; Multiple sclerosis; Plaque psoriasis
- Focus Pharmacokinetics
- Sponsors Actelion Pharmaceuticals
- 16 Feb 2016 Results published in the European Journal of Drug Metabolism and Pharmacokinetics
- 20 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 18 Sep 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.